The experimental correction of the dysbacteriosis by probiotics

Abstract

In vivo, the obtained evidences were received to necessitate the performance of the standard preclinical research of different dosages of the probiotics in experimental model of the probiotics treatment efficiency study in the case of dysbacteriosis correction. The use of different commercial probiotics in the experimental disbiosis lead to various results of the corrections of intestinal microflora balance: to the increasing of normoflora without the correction of potentially harmful organisms in case of using the normoflora medication; to the increasing of lactose-positive E.coli, lactobacteria, without the bifidobacteria level shifting and to the elimination of fungi and staphylococcus in case of the biosporin. Bactisubtil didn't restore the normoflora and didn't correct the level of the fungi and staphylococcus